Compound 1358
Identifiers
- Canonical SMILES:
CC(C)C1=C(SC2=N[C@](C)([C@H](N12)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(=O)N1CCC[C@H]1c1nnn[nH]1
- IUPAC name:
[(5R,6S)-5,6-bis(4-chlorophenyl)-6-methyl-3-propan-2-yl-5H-imidazo[2,1-b][1,3]thiazol-2-yl]-[(2S)-2-(2H-tetrazol-5-yl)pyrrolidin-1-yl]methanone
- InChi:
InChI=1S/C27H27Cl2N7OS/c1-15(2)21-22(25(37)35-14-4-5-20(35)24-31-33-34-32-24)38-26-30-27(3,17-8-12-19(29)13-9-17)23(36(21)26)16-6-10-18(28)11-7-16/h6-13,15,20,23H,4-5,14H2,1-3H3,(H,31,32,33,34)/t20-,23+,27-/m0/s1
- InChiKey:
REHKEFZCVMTLBW-OSADXMDESA-N
External links
![]() 58007010 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 6.71 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 567.14 g/mol | |||
HBA | 8 | |||
HBD | 1 | |||
HBA + HBD | 9 | |||
AlogP | 5.33 | |||
TPSA | 90.37 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2008072655 | 99 | MDM2 Q00987 |
|
Biochemical assay | Time-Resolved FRET | pIC50 (half maximal inhibitory concentration, -log10) | 6.71 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4109 | (5Z)-5-[(5-ethylfuran-2-yl)methylidene]-2-[[(S)-(4-fluorophenyl)-(2H-tetrazol-5-yl)methyl]amino]-1,3-thiazol-4-one | DB08710 | |
0.3892 | RO-5045337 | DB14793 | |
0.3773 | Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone | DB04144 | |
0.3713 | ONC-201 | DB14844 | |
0.3680 | Levamisole | DB00848 | |
0.3552 | Br-Coeleneterazine | DB02006 | |
0.3536 | N-Coeleneterazine | DB04118 | |
0.3534 | I-Coeleneterazine | DB04146 | |
0.3489 | Cp-Coeleneterazine | DB03960 | |
0.3472 | Cefoperazone | DB01329 | |
0.3463 | Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone | DB02872 | |
0.3398 | Cefiderocol | DB14879 | |
0.3377 | Cefpiramide | DB00430 | |
0.3372 | (2S)-({(5Z)-5-[(5-Ethyl-2-furyl)methylene]-4-oxo-4,5-dihydro-1,3-thiazol-2-yl}amino)(4-fluorophenyl)acetic acid | DB08706 | |
0.3352 | Ponesimod | DB12016 |